Pancreatic Cancer Research

Preprint2021

Survival Outcomes Among Pancreatic Cancer Patients at Kenyatta National Hospital

Published
25 August 2021
Citations
0
Type
Preprint
License
cc by

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract cc by

Abstract Purpose: The mortality rate of pancreatic cancer varies throughout the world, with industrialized countries being hard hit. In addition, mortality has risen fast in the past two decades in Kenya and East Africa. However, there was a paucity of conclusive data about the survival of pancreatic cancer patients in the study setting. Hence, this study aimed to assess the survival outcomes of pancreatic cancer patients at Kenyatta National Hospital.Methods: A hospital-based retrospective cohort analysis was used to evaluate the survival outcomes among pancreatic cancer patients admitted in the study setting between 2015 and 2019. A total of 64 eligible pancreatic cancer patients were included in the study. In the pre-designed data abstraction tool, the data were collected by reviewing the medical records of the patients. The data were entered and analyzed using the Statistical Package for the Social Sciences version 22 software. The mean survival time was estimated using Kaplan Meier survival analysis. Cox regression analysis was employed to estimate the predictors of mortality among pancreatic cancer patients.Results: The mean age of the study participants was 60.38±12.61 years. Most of the patients had adenocarcinoma (96.9%) and were diagnosed at an advanced stage of the disease. The overall mean and median survival estimate for pancreatic cancer was 48.7±9.7 and 39.0±23.9 months, respectively. The present study showed that the overall survival rate of pancreatic cancer patients was 79.7%. Conclusion: The mortality rate of pancreatic cancer in the present was 20%. The overall mean survival estimate for pancreatic cancer was 48.7±9.7 months, and the majority had disease progression in the last follow-up period.